SYNH Stock Price, Chart, Stats & News

Syneos Health, Inc.
Save
4.46B
Market cap
61.40x
Current P/E
–
Forward P/E
SYNH chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 23.26% |
Operating margin | 7.48% |
Pretax margin | 5.83% |
Net margin | 4.94% |
Effective tax rate | 15.28% |
ROA | 3.25% |
ROE | 7.72% |
D/E | 0.83x |
Interest coverage ratio | 4.99x |
SYNH valuation
P/E | 61.40x |
P/S | 0.83x |
P/B | 1.27x |
P/CF | 10.37x |
P/FCF | 13.37x |
P/OCF | 10.37x |
PEG | 0.17x |
EV multiple | 2.39x |
About
Syneos Health, Inc. is a prominent global provider of outsourced biopharmaceutical services, operating with a vast reach across North America, Europe, the Middle East, Africa, the Asia-Pacific region, and Latin America. The company structures its offerings into two principal segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment is dedicated to supporting the complete clinical development journey, from Phase I through IV, for a diverse array of medical innovations including diagnostics, drugs, biologics, devices, and digital therapeutics.
Similar securities
Based on sector and market capitalization
Report issue











